XSHE
300261
Market cap697mUSD
Oct 09, Last price
4.90CNY
1D
1.03%
1Q
9.13%
Jan 2017
-24.03%
IPO
40.00%
Name
Aba Chemicals Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 2003 and headquartered in Taicang, China, ABA Chemicals Corporation is a global enterprise dedicated to the research, development, and manufacturing of a diverse array of chemical products. The company's primary focus includes crop protection solutions, offering substances like plant growth regulators, herbicides, insecticides, and bactericides. Furthermore, ABA Chemicals produces vital intermediates for both pharmaceutical and agrochemical industries, in addition to supplying a variety of nutritional and health-related goods.
Key people
Aijun Wang
Chief Financial Officer, Director · since 2025
Yueheng Jiang
Deputy General Manager · since 2012
Zhigang Lin
Deputy General Manager · since 2019
Zhuoying Wang
Deputy General Manager, Director · since 2022
Yichuan Wang
Deputy General Manager, Secretary of the Board · since 2022
Tong Cai
Chairman of the Board, General Manager
Hang Li
Director · since 2022
Limin Que
Director · since 2025
Jun Xu
Director · since 2025
Yanchao Rao
Independent Director · since 2022
Jia Yan
Independent Director · since 2022
Jun Zhang
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||